Rate this post

Hiya and joyful hump day, readers!

This morning, Fortune got here out with its newest listing of the 40 entrepreneurs, leaders, and iconoclasts who’re nonetheless “beneath the hill”—our 2019 40 Underneath 40. And, as luck would have it, it options some fascinating well being care-focused expertise.

That features Mei Mei Hu, the co-founder and CEO of United Neuroscience, whose firm is attempting to make an Alzheimer’s vaccine; Trevor Martin, the wunderkind is not slightly below 40, however barely 30 and taking a brand new strategy to CRISPR gene-editing tech; and Keller Rinaudo, whose drone firm is doing one thing that is roughly the other of the issues one would possibly affiliate with drones.

Your complete listing is nice and properly value your time. I hope you flick through it.

Learn on for the day’s information.

Sy Mukherjee, @the_sy_guy, [email protected]


Former Illumina accountant charged in insider buying and selling scheme. The Securities and Change Fee (SEC) has filed insider buying and selling fees in opposition to a former accountant on the genetic sequencing powerhouse Illumina for allegedly tipping off her good friend (additionally named within the criticism) about quarterly earnings. In return, the criticism says, the accountant would obtain all-expense paid journey and different such presents; the scheme allegedly generated some $6.2 million in earnings. (SEC)


As EpiPen scarcity drags, Novartis to promote generic allergy shot. Keep in mind the EpiPen scarcity—linked to each generic drug big Mylan and its manufacturing associate Pfizer? It’s nonetheless going sturdy, and it’s giving different main pharmaceutical firms a gap to get in available on the market. The newest is Switzerland’s Novartis, whose generic unit Sandoz will now launch its personal EpiPen various, Symjepi, in pharmacies following an preliminary transfer to make it obtainable to hospitals. And it’s undercutting the value of Mylan’s “approved generic” model of the EpiPen by $50. (Reuters)


Examine: Cease with the dietary supplements, eat precise meals. A large meta-analysis of diet and vitamin dietary supplements involves a conclusion some public well being consultants have been trumpeting for years: Total, many dietary adjustments and dietary dietary supplements at massive don’t truly do something. In truth, there might even be some total hurt to taking sure dietary supplements. There’s, nonetheless, some nuance: “Decreased salt consumption, omega-Three LC-PUFA use, and folate supplementation may scale back threat for some cardiovascular outcomes in adults. Mixed calcium plus vitamin D would possibly enhance threat for stroke,” the research authors wrote. (Gizmodo)


40 Underneath 40: Recommendation That Helped Them Get Forwardby Megan Arnold

How Millennials Are Altering the Face of Managementby Ed Frauenheim

Designing a Welcoming Company Traditionby Ellen McGirt

Visa Pours Tens of millions into Cryptocurrency Startup Anchorageby Robert Hackett

Discover previous protection. Join different Fortune newsletters.